Developing CAR-immune cell therapy against SARS-COV-2: Current status, challenges, and prospects

Y Chen, C Liu, Y Fang, W Chen, J Qiu, M Zhu… - Biochemical …, 2024 - Elsevier
Chimeric antigen receptor (CAR)-immune cell therapy has revolutionized the anti-tumor
field, achieving efficient and precise tumor clearance by directly guiding immune cell activity …
被引用次数：1 相关文章

Developing CAR-immune cell therapy against SARS-COV-2: Current status, challenges, and prospects.

Y Chen, C Liu, Y Fang, W Chen, J Qiu… - Biochemical …, 2024 - europepmc.org
Chimeric antigen receptor (CAR)-immune cell therapy has revolutionized the anti-tumor
field, achieving efficient and precise tumor clearance by directly guiding immune cell activity …

Developing CAR-immune cell therapy against SARS-COV-2: Current status, challenges, and prospects

Y Chen, C Liu, Y Fang, W Chen, J Qiu… - Biochemical … - pubmed.ncbi.nlm.nih.gov
Chimeric antigen receptor (CAR)-immune cell therapy has revolutionized the anti-tumor
field, achieving efficient and precise tumor clearance by directly guiding immune cell activity …